Yi-Xiao Wang (Yixiao Wang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Combination Therapy

Vascular Endothelial Growth Factor

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Acta ophthalmologica

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Xiao Wang, Aaron Snell, Frank M Dyka, Elizabeth R Colvin, Cristhian J Ildefonso, John D Ash, Ekaterina S Lobanova
Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness. Science advances 9 (28) (2023)
Yi-Xiao Wang, Claudio Punzo, John D Ash, Ekaterina S Lobanova
Tsc2 knockout counteracts ubiquitin-proteasome system insufficiency and delays photoreceptor loss in retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 119 (11) (2022)
Teng-Teng Yao, Yuan Yang, Xiao-Liang Jin, Yi-Xiao Wang, Ya-Li Zhou, A-Jing Xu, Fang-Lin He, Zhao-Yang Wang
Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study. Acta ophthalmologica 98 (7) (2020)